Ep 6: Inflammatory Biomarkers and Cardiovascu...

In this Redcliffe Cardiology NVM reflections episode, Prof Nicolas Van Mieghem cuts through the noise from TCT 2025. Tune in to hear what the SELUTION trials mean for drug-coated balloons in de novo disease and ISR, why cost and sizing matter in calcium modification, how PE throm ...  Show more

At TCT 2025, Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr. Rahul P. Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease. The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricu ...  Show more

In this episode, Amrut Ambardekar MD and Michelle Kittleson MD discuss red flags and clinical clues when diagnosing cardiac amyloidosis. Why is it important to diagnose cardiac amyloidosis, and what are some of the symptoms and signs? What are some red-flags that should make you ...  Show more

In this episode, Editor-in-Chief Harlan Krumholz explores the evolving landscape of cardiovascular medicine, beginning with a call for responsible stewardship of artificial intelligence. Highlights include a major registry study on percutaneous aspiration for right-sided endocard ...  Show more

Does thinking about myocarditis make your chest hurt? In this episode, we have a fantastic heart-to-heart with Dr. Jessica Laks (Heart Failure and Transplant at Johns Hopkins All Children’s Hospital). Together, we dive into the complexities of myocarditis - how to recognize the s ...  Show more

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay In this episode, I will be covering in detail the effect of Beta Blockers on CardioVascular System and details about states of exercise/stress and Coronary Heart Disease. I will also talk about the Antihypert ...  Show more